Fellowship · Memphis, TN
Sponsored by University of Tennessee College of Medicine
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.
The New England journal of medicine · 2025 · 227 citations · Aditya Gaur
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
The New England journal of medicine · 2021 · 759 citations · Aditya Gaur
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.
The New England journal of medicine · 2023 · 422 citations · Karen Slobod
Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update.
Infection control and hospital epidemiology · 2022 · 319 citations · Joshua Wolf
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape.
The Lancet. Infectious diseases · 2023 · 325 citations · Asunción Mejías, Octavio Ramilo
Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
Lancet (London, England) · 2024 · 165 citations ·
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.
Transplantation and cellular therapy · 2023 · 331 citations · Gabriela Marón
Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 163 citations · Joshua Wolf